Abstract
Introduction
Whether transplanted cardiac stem cells (CSCs) and mesenchymal stem cells (MSCs) improved ventricular fibrillation threshold (VFT) similarly is still unclear. We sought to compare the effects of the CSC and MSC transplantation on the electrophysiological characteristics and VFT in rats with myocardial infarction (MI).
Methods
MI was induced in 30 male Sprague–Dawley rats. Two weeks later, animals were randomized to receive 5 × 106 CSCs labeled with PKH26 in PBS or 5 × 106 MSCs labeled with PKH26 in phosphate buffer solution(PBS) or PBS alone injection into the infarcted anterior ventricular free wall. Six weeks after the injection, electrophysiological characteristics and VFT were measured. Labeled CSCs and MSCs were observed in 5 μm cryostat sections from each heart.
Results
Malignant ventricular arrhythmias were significantly (P = 0.0055) less inducible in the CSC group than the MSC group. The VFTs were improved in the CSC group compared with the MSC group. Labeled CSCs and MSCs were identified in the infarct zone and infarct marginal zone. Labeled CSCs expressed Connexin-43, von Willebrand factor, α-smooth muscle actin and α-sarcomeric actin,while the Labeled MSCs expressed von Willebrand factor, α-smooth muscle actin and α-sarcomeric actin in vivo.
Conclusions
After 6 weeks of cell transplantation, CSCs are superior to MSCs in modulating the electrophysiological abnormality and improving the VFT in rats with MI. CSCs and MSCs express markers that suggest muscle, endothelium and vascular smooth muscle phenotypes in vivo, but MSCs rarely express Connexin-43.
Similar content being viewed by others
Abbreviations
- ART:
-
Activation recovery time
- ARTd:
-
ART dispersion
- ARTc:
-
Correct ART
- ARTcd:
-
ARTc dispersion
- Cx43:
-
Connexin-43
- CSCs:
-
Cardiac stem cells
- MSCs:
-
Mesenchymal stem cells
- MI:
-
Myocardial infarction
- PBS:
-
Phosphate buffer solution
- VT:
-
Ventricular tachycardia
- VFT:
-
Ventricular fibrillation threshold
- VF:
-
Ventricular fibrillation
References
Oettgen, P., Boyle, A. J., Schulman, S. P., & Hare, J. M. (2006). Cardiac stem cell therapy; need for optimization of efficacy and safety monitoring. Circulation, 14, 353–358.
Herrmann, J. L., Abarbanell, A. M., Weil, B. R., Wang, Y., Wang, M., Tan, J., & Meldrum, D. R. (2009). Cell-based therapy for ischemic heart disease: a clinical update. The Annals of Thoracic Surgery, 88, 1714–1722.
LaPar, D. J., Kron, I. L., & Yang, Z. (2009). Stem cell therapy for ischemic heart disease: where are we? Current Opinion in Organ Transplantation, 14, 79–84.
Durrani, S., Konoplyannikov, M., Ashraf, M., & Haider, K. H. (2010). Skeletal myoblasts for cardiac repair. Regenerative Medicine, 5(6), 919–932.
Menasché, P. (2009). Cell therapy: results in cardiology. Bulletin de l’Académie Nationale de Médecine, 193, 559–568.
Schachinger, V., Erbs, S., Elsasser, A., Haberbosch, W., Hambrecht, R., Hölschermann, H., Yu, J., Corti, R., Mathey, D. G., Hamm, C. W., Süselbeck, T., Assmus, B., Tonn, T., Dimmeler, S., Zeiher, A. M., & Investigators, R. E. P. A. I. R.-A. M. I. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. The New England Journal of Medicine, 355, 1210–1221.
Beltrami, A. P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., Kasahara, H., Rota, M., Musso, E., Urbanek, K., Leri, A., Kajstura, J., Nadal-Ginard, B., & Anversa, P. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 114, 763–776.
Bearzi, C., Rota, M., Hosoda, T., Tillmanns, J., Nascimbene, A., De Angelis, A., Yasuzawa-Amano, S., Trofimova, I., Siggins, R. W., Lecapitaine, N., Cascapera, S., Beltrami, A. P., D’Alessandro, D. A., Zias, E., Quaini, F., Urbanek, K., Michler, R. E., Bolli, R., Kajstura, J., Leri, A., & Anversa, P. (2007). Human cardiac stem cells. Proceedings of the National Academy of Sciences of the United States of America, 104, 14068–14073.
Zheng, S., Zhou, C., Weng, Y., Huang, H., Wu, H., Huang, J., Wu, W., Sun, S., Wang, J., Tang, W., & Wang, T. (2011). Improvements of cardiac electrophysiologic stability and ventricular fibrillation threshold in rats with myocardial infarction treated with cardiac stem cells. Critical Care Medicine, 39(5), 1082–1088.
Kajstura, J., Urbanek, K., Rota, M., Bearzi, C., Hosoda, T., Bolli, R., Anversa, P., & Leri, A. (2008). Cardiac stem cells and myocardial disease. Journal of Molecular and Cellular Cardiology, 45, 505–513.
Wang, T., Tang, W., Sun, S., Ristagno, G., Huang, Z., & Weil, M. H. (2007). Intravenous infusion of bone marrow mesenchymal stem cells improves myocardial function in a rat model of myocardial ischemia. Critical Care Medicine, 35, 2587–2593.
Mias, C., Lairez, O., Trouche, E., Roncalli, J., Calise, D., Seguelas, M. H., Ordener, C., Piercecchi-Marti, M. D., Auge, N., Salvayre, A. N., Bourin, P., Parini, A., & Cussac, D. (2009). Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells, 27(11), 2734–2743.
Zhang, F., & Pasumarthi, K. B. (2008). Embryonic stem cell transplantation: promise and progress in the treatment of heart disease. BioDrugs, 22(6), 361–374.
Tang, X. L., Rokosh, G., Sanganalmath, S. K., Yuan, F., Sato, H., Mu, J., Dai, S., Li, C., Chen, N., Peng, Y., Dawn, B., Hunt, G., Leri, A., Kajstura, J., Tiwari, S., Shirk, G., Anversa, P., & Bolli, R. (2010). Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation, 121(2), 293–305.
Chang, M. G., Tung, L., Sekar, R. B., Chang, C. Y., Cysyk, J., Dong, P., Marbán, E., & Abraham, M. R. (2006). Proarrhythmic potential of mesenchymal stem cell transplantation revealed in an in vitro coculture model. Circulation, 113, 1832–1841.
Mills, W. R., Mal, N., Kiedrowski, M. J., Unger, R., Forudi, F., Popovic, Z. B., Penn, M. S., & Laurita, K. R. (2007). Stem cell therapy enhances electrical viability in myocardial infarction. Journal of Molecular and Cellular Cardiology, 42(2), 304–314.
Zhang, Y. M., Hartzell, C., Narlow, M., & Dudley, S. C., Jr. (2002). Stem cell-derived cardiomyocytes demonstrate arrhythmic potential. Circulation, 106, 1294–1299.
Chamuleau, S. A., Vrijsen, K. R., Rokosh, D. G., Tang, X. L., Piek, J. J., & Bolli, R. (2009). Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells. Netherlands Heart Journal, 17, 199–207.
Smits, P. C., van Geuns, R. J., Poldermans, D., Bountioukos, M., Onderwater, E. E., Lee, C. H., Maat, A. P., & Serruys, P. W. (2003). Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. Journal of the American College of Cardiology, 42, 2063–2069.
Fernandes, S., Amirault, J. C., Lande, G., Nguyen, J. M., Forest, V., Bignolais, O., Lamirault, G., Heudes, D., Orsonneau, J. L., Heymann, M. F., Charpentier, F., & Lemarchand, P. (2006). Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias. Cardiovascular Research, 69, 348–358.
Parker, C. (2007). Ethics for embryos. Journal of Medical Ethics, 33(10), 614–616.
Li, Q., Turdi, S., Thomas, D. P., Zhou, T., & Ren, J. (2010). Intra-myocardial delivery of mesenchymal stem cells ameliorates left ventricular and cardiomyocyte contractile dysfunction following myocardial infarction. Toxicology Letters, 195(2–3), 119–126.
Smith, R. R., Barile, L., Cho, H. C., Leppo, M. K., Hare, J. M., Messina, E., Giacomello, A., Abraham, M. R., & Marbán, E. (2007). Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation, 115, 896–908.
Hosoda, T., Kajstura, J., Leri, A., & Anversa, P. (2010). Mechanisms of myocardial regeneration. Circulation Journal, 74, 13–17.
Kajstura, J., Gurusamy, N., Ogórek, B., Goichberg, P., Clavo-Rondon, C., Hosoda, T., D’Amario, D., Bardelli, S., Beltrami, A. P., Cesselli, D., Bussani, R., del Monte, F., Quaini, F., Rota, M., Beltrami, C. A., Buchholz, B. A., Leri, A., & Anversa, P. (2010). Myocyte turnover in the aging human heart. Circulation Research, 107, 1374–1386.
Kajstura, J., Urbanek, K., Perl, S., Hosoda, T., Zheng, H., Ogórek, B., Ferreira-Martins, J., Goichberg, P., Rondon-Clavo, C., Sanada, F., D’Amario, D., Rota, M., Del Monte, F., Orlic, D., Tisdale, J., Leri, A., & Anversa, P. (2010). Cardiomyogenesis in the adult human heart. Circulation Research, 107, 305–315.
Wang, T., Tang, W., Sun, S., Ristagno, G., Xu, T., & Weil, M. H. (2009). Improved outcomes of cardiopulmonary resuscitation in rats with myocardial infarction treated with allogenic bone marrow mesenchymal stem cells. Critical Care Medicine, 37(3), 833–839.
Wang, T., Tang, W., Sun, S., Wan, Z., Xu, T., Huang, Z., & Weil, M. H. (2009). Mesenchymal stem cells improve outcomes of cardiopulmonary resuscitation in myocardial infarcted rats. Journal of Molecular and Cellular Cardiology, 46, 378–384.
Wang, T., Tang, W., Sun, S., Xu, T., Wang, H., Guan, J., Huang, Z., & Weil, M. H. (2008). Intravenous infusion of bone marrow mesenchymal stem cells improves brain function after resuscitation from cardiac arrest. Critical Care Medicine, 36, S486–S491.
Xia, Y., Kongstad, O., Hertervig, E., Li, Z., Holm, M., Olsson, B., & Yuan, S. (2005). Activation recovery time measurements in evaluation of global sequence and dispersion of ventricular repolarization. Journal of Electrocardiology, 38, 28–35.
Wang, H., Tang, W., Ristagno, G., Li, Y., Sun, S., Wang, T., & Weil, M. H. (2009). The potential mechanisms of reduced incidence of ventricular fibrillation as the presenting rhythm in sudden cardiac arrest. Critical Care Medicine, 37, 26–31.
Padin-Iruegas, M. E., Misao, Y., Davis, M. E., Segers, V. F., Esposito, G., Tokunou, T., Urbanek, K., Hosoda, T., Rota, M., Anversa, P., Leri, A., Lee, R. T., & Kajstura, J. (2009). Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation, 120, 876–887.
Shyu, K. Y., Wang, B. W., Hung, H. F., Chang, C. C., & Shih, D. T. (2006). Mesenchymal stem cells are superior to angiogenic growth factor genes for improving myocardial performance in the mouse model of acute myocardial infarction. Journal of Biomedical Science, 13, 47–58.
Sun, Y. (2009). Myocardial repair/remodeling following infarction: roles of local factors. Cardiovascular Research, 81, 482–490.
Sharma, R., & Raghubir, R. (2007). Stem cell therapy: a hope for dying hearts. Stem Cells and Development, 16, 517–536.
Menasché, P. (2009). Stem cell therapy for heart failure: are arrhythmias a real safety concern? Circulation, 119, 2735–2740.
Ly, H. Q., & Nattel, S. (2009). Stem cells are not proarrhythmic: letting the genie out of the bottle. Circulation, 119, 1824–1831.
Makkar, R. R., Lill, M., & Chen, P. S. (2003). Stem cell therapy for myocardial repair: is it arrhythmogenic? Journal of the American College of Cardiology, 42, 2070–2072.
Makino, S., Fukuda, K., Miyoshi, S., Konishi, F., Kodama, H., Pan, J., Sano, M., Takahashi, T., Hori, S., Abe, H., Hata, J., Umezawa, A., & Ogawa, S. (1999). Cardiomyocytes can be generated from marrow stromal cells in vitro. The Journal of Clinical Investigation, 103, 697–705.
Wang, T., Xu, Z., Jiang, W., & Ma, A. (2006). Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. International Journal of Cardiology, 109, 74–81.
Liechty, K. W., MacKenzie, T. C., Shaaban, A. F., Radu, A., Moseley, A. M., Deans, R., Marshak, D. R., & Flake, A. W. (2000). Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nature Medicine, 6, 1282–1286.
Piao, H., Youn, T. J., Kwon, J. S., Kim, Y. H., Bae, J. W., Bora-Sohn, S., Kim, D. W., Cho, M. C., Lee, M. M., & Park, Y. B. (2005). Effects of bone marrow derived mesenchymal stem cells transplantation in acutely infarcting myocardium. European Journal of Heart Failure, 7, 730–738.
Jiang, W., Ma, A., Wang, T., Han, K., Liu, Y., Zhang, Y., Dong, A., Du, Y., Huang, X., Wang, J., Lei, X., & Zheng, X. (2006). Homing and differentiation of mesenchymal stem cells delivered intravenously to ischemic myocardium in vivo: a time-series study. Pflügers Archiv, 453, 43–52.
Quevedo, H. C., Hatzistergos, K. E., Oskouei, B. N., Feigenbaum, G. S., Rodriguez, J. E., Valdes, D., Pattany, P. M., Zambrano, J. P., Hu, Q., McNiece, I., Heldman, A. W., & Hare, J. M. (2009). Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proceedings of the National Academy of Sciences of the United States of America, 106, 14022–14027.
Berry, M. F., Engler, A. J., Woo, Y. J., Pirolli, T. J., Bish, L. T., Jayasankar, V., Morine, K. J., Gardner, T. J., Discher, D. E., & Sweeney, H. L. (2006). Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. American Journal of Physiology - Heart and Circulatory Physiology, 290, H2196–H2203.
Wen, Z., Zheng, S., Zhou, C., Wang, J., & Wang, T. (2010). Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. Journal of Cellular and Molecular Medicine, 15(5), 1032–1043.
Dai, W., Hale, S. L., Martin, B. J., Kuang, J. Q., Dow, J. S., Wold, L. E., & Kloner, R. A. (2005). Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation, 112, 214–223.
Rose, R. A., Jiang, H., Wang, X., Helke, S., Tsoporis, J. N., Gong, N., Keating, S. C., Parker, T. G., Backx, P. H., & Keating, A. (2008). Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro. Stem Cells, 26, 2884–2892.
Gui, R., Li, H. Y., Sun, X. L., & Lau, C. P. (2005). Characterization of ionic currents in human mesenchymal stem cells from bone marrow. Stem Cells, 23, 371–382.
Heubach, J. F., Graf, E. M., Leut, H. J., Bock, M., Balana, B., Zahanich, I., Christ, T., Boxberger, S., Wettwer, E., & Ravens, U. (2004). Electrophysilogical properties of human mesenchymal stem cells. The Journal of Physiology, 554, 659–672.
Smith, R. R., Barile, L., Messina, E., & Marbán, E. (2008). Stem cells in the heart: what’s the buzz all about? Part 2: Arrhythmic risks and clinical studies. Heart Rhythm, 5, 880–887.
Young, B., Kim, I. K., Lee, M. H., Yoo, K. J., & Kim, S. S. (2007). Bone marrow mononuclear stem cells transplanted in rat infarct myocardium improved the electrical conduction without evidence of proarrhythmic effects. Yonsei Medical Journal, 48(5), 754–764.
Price, M. J., Chou, C. C., Frantzen, M., Miyamoto, T., Kar, S., Lee, S., Shah, P. K., Martin, B. J., Lill, M., Forrester, J. S., Chen, P. S., & Makkar, R. R. (2006). Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties. International Journal of Cardiology, 111, 231–239.
Schuleri, K. H., Feigenbaum, G. S., Centola, M., Weiss, E. S., Zimmet, J. M., Turney, J., Kellner, J., Zviman, M. M., Hatzistergos, K. E., Detrick, B., Conte, J. V., McNiece, I., Steenbergen, C., Lardo, A. C., & Hare, J. M. (2009). Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. European Heart Journal, 30, 2722–2732.
Hare, J. M., Traverse, J. H., Henry, T. D., Dib, N., Strumpf, R. K., Schulman, S. P., Gerstenblith, G., DeMaria, A. N., Denktas, A. E., Gammon, R. S., Hermiller, J. B., Jr., Reisman, M. A., Schaer, G. L., & Sherman, W. (2009). A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. Journal of the American College of Cardiology, 54, 2277–2286.
Leri, A., Kajstura, J., & Anversa, P. (2005). Cardiac stem cells and mechanisms of myocardial regeneration. Physiological Reviews, 85, 1373–1416.
Dawn, B., Stein, A. B., Urbanek, K., Rota, M., Whang, B., Rastaldo, R., Torella, D., Tang, X. L., Rezazadeh, A., Kajstura, J., Leri, A., Hunt, G., Varma, J., Prabhu, S. D., Anversa, P., & Bolli, R. (2005). Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proceedings of the National Academy of Sciences of the United States of America, 102, 3766–3771.
de Boer, T. P., van Veen, T. A., Jonsson, M. K., Kok, B. G., Metz, C. H., Sluijter, J. P., Doevendans, P. A., de Bakker, J. M., Goumans, M. J., & van der Heyden, M. A. (2010). Human cardiomyocyte progenitor cell-derived cardiomyocytes display a maturated electrical phenotype. Journal of Molecular and Cellular Cardiology, 48, 254–260.
Wang, D., Zhang, F., Shen, W., Chen, M., Yang, B., Zhang, Y., & Cao, K. (2010). Mesenchymal stem cell injection ameliorates the inducibility of ventricular arrhythmias after myocardial infarction in rats. International Journal of Cardiology, 152(3), 314–320.
Wang, D., Shen, W., Zhang, F., Chen, M., Chen, H., & Cao, K. (2010). Connexin 43 promotes survival of mesenchymal stem cells in ischemic heart. Cell Biology International, 34, 415–423.
van Rijen, H. V., Eckardt, D., Degen, J., Theis, M., Ott, T., Willecke, K., Jongsma, H. J., Opthof, T., & de Bakker, J. M. (2004). Slow conduction and enhanced anisotropy increase the propensity for ventricular tachyarrhythmias in adult mice with induced deletion of connexin43. Circulation, 109, 1048–1055.
Malliaras, K., Li, T. S., Luthringer, D., Terrovitis, J., Cheng, K., Chakravarty, T., Galang, G., Zhang, Y., Schoenhoff, F., Van Eyk, J., Marbán, L., & Marbán, E. (2012). Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells. Circulation, 125, 100–112.
Bolli, R., Chugh, A. R., D’Amario, D., Loughran, J. H., Stoddard, M. F., Ikram, S., Beache, G. M., Wagner, S. G., Leri, A., Hosoda, T., Sanada, F., Elmore, J. B., Goichberg, P., Cappetta, D., Solankhi, N. K., Fahsah, I., Rokosh, D. G., Slaughter, M. S., Kajstura, J., & Anversa, P. (2011). Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet, 378, 1847–1857.
Funding
This study supported by National Natural Science Foundation of China (No: 81070125 and No: 30971262), Natural Science Foundation of Guangdong Province (No: 8151008901000119) and Science and Technology Foundation in Guangdong Province (No: 2010B031600032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author details
The Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China.
Authors’ contributions
TW, SXZ, YLW and JFW contributed to the conception and design of the study protocol. SXZ, YLW, CQZ and ZZW participated in the coordination of the study and data collection. WW and HH contributed to the analysis and interpretation of the data. All authors were involved in drafting the manuscript or revising it critically for important intellectual content. All authors read and gave final approval of the present version of the manuscript to be published.
Competing Interests
The authors have not disclosed any potential conflicts of interest.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Dr. Shao-Xin Zheng and Dr. Yin-Lun Weng played equally important roles in the development of the experimental protocol, in the interpretation of the results, and in the texture of the present article.
Rights and permissions
About this article
Cite this article
Zheng, SX., Weng, YL., Zhou, CQ. et al. Comparison of Cardiac Stem Cells and Mesenchymal Stem Cells Transplantation on the Cardiac Electrophysiology in Rats with Myocardial Infarction. Stem Cell Rev and Rep 9, 339–349 (2013). https://doi.org/10.1007/s12015-012-9367-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-012-9367-6